This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.
Document identifier
CLSI NBS05
Title
Newborn Screening for Cystic Fibrosis, 2nd Edition, NBS05Ed2E
CLSI Category
Immunology and Ligand Assay
Publication date
2019-12-01
International Relationship
History of version
CLSI NBS05 * CLSI NBS05-A * CLSI I/LA35-A
Price |
140 vnd |